| References |
| 1 |
Midostaurin: an emerging treatment for acute myeloid leukemia patients
|
| 2 |
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth
|
| 3 |
Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans. Toxicol Appl Pharmacol. 1995 Aug;133(2):295-304.
|
| 4 |
Final report on the safety assessment of Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate
|
| 5 |
Bioactivation of benzylamine to reactive intermediates in rodents: formation of glutathione, glutamate, and peptide conjugates
|
| 6 |
Identification of naphthalene metabolism by white rot fungus Pleurotus eryngii
|
| 7 |
DrugBank(Pharmacology-Metabolism)Amphetamine
|
| 8 |
The Degradation Chemistry of Farglitazar and Elucidation of the Oxidative Degradation Mechanisms
|
| 9 |
High gastrointestinal permeability and local metabolism of naringenin: influence of antibiotic treatment on absorption and metabolism
|
| 10 |
Metabolism of ( 14 C)methamphetamine in man, the guinea pig and the rat
|
| 11 |
Preclinical pharmacokinetics, pharmacology and toxicology of lisdexamfetamine: a novel d-amphetamine pro-drug. Neuropharmacology. 2014 Dec;87:41-50.
|
| 12 |
In vitro catabolism of 3',4'-dihydroxycinnamic acid by human colonic microbiota
|
| 13 |
Metabolism of trans-cinnamic acid in the rat and the mouse and its variation with dose
|
| 14 |
Biotransformation of two citrus flavanones by lactic acid bacteria in chemical defined medium
|
| 15 |
Midostaurin, a novel protein kinase inhibitor for the treatment of acute myelogenous leukemia: insights from human absorption, metabolism, and excretion studies of a BDDCS II drug. Drug Metab Dispos. 2017 May;45(5):540-555.
|
